ATE312940T1 - Chromogenischen enzymsubstraten und verfahren zum nachweis von beta-d-ribofuranosidase-wirksamkeit - Google Patents

Chromogenischen enzymsubstraten und verfahren zum nachweis von beta-d-ribofuranosidase-wirksamkeit

Info

Publication number
ATE312940T1
ATE312940T1 AT02772539T AT02772539T ATE312940T1 AT E312940 T1 ATE312940 T1 AT E312940T1 AT 02772539 T AT02772539 T AT 02772539T AT 02772539 T AT02772539 T AT 02772539T AT E312940 T1 ATE312940 T1 AT E312940T1
Authority
AT
Austria
Prior art keywords
ribofuranosidase
substrate
effectiveness
enzyme substrates
detecting
Prior art date
Application number
AT02772539T
Other languages
English (en)
Inventor
Michael Burton
Original Assignee
Michael Burton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0125528A external-priority patent/GB0125528D0/en
Priority claimed from GB0221716A external-priority patent/GB0221716D0/en
Application filed by Michael Burton filed Critical Michael Burton
Application granted granted Critical
Publication of ATE312940T1 publication Critical patent/ATE312940T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT02772539T 2001-10-24 2002-10-24 Chromogenischen enzymsubstraten und verfahren zum nachweis von beta-d-ribofuranosidase-wirksamkeit ATE312940T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0125528A GB0125528D0 (en) 2001-10-24 2001-10-24 Enzyme substrates
GB0221716A GB0221716D0 (en) 2002-09-18 2002-09-18 Chromogenic enzyme substrates
PCT/GB2002/004800 WO2003035896A2 (en) 2001-10-24 2002-10-24 Chromogenic enzyme substrates and method for detecting beta-d-ribofuranosidase activity

Publications (1)

Publication Number Publication Date
ATE312940T1 true ATE312940T1 (de) 2005-12-15

Family

ID=26246694

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02772539T ATE312940T1 (de) 2001-10-24 2002-10-24 Chromogenischen enzymsubstraten und verfahren zum nachweis von beta-d-ribofuranosidase-wirksamkeit
AT02770105T ATE316148T1 (de) 2001-10-24 2002-10-24 Enzymsubstrate zum nachweis der beta-d- ribofuranosidase aktivität

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02770105T ATE316148T1 (de) 2001-10-24 2002-10-24 Enzymsubstrate zum nachweis der beta-d- ribofuranosidase aktivität

Country Status (7)

Country Link
US (3) US7323488B2 (de)
EP (2) EP1438424B1 (de)
AT (2) ATE312940T1 (de)
AU (2) AU2002337302A1 (de)
DE (2) DE60208063T2 (de)
ES (2) ES2254745T3 (de)
WO (2) WO2003035897A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344854B2 (en) * 1999-07-20 2008-03-18 Micrology Laboratories, Llc Test media for quantitative or qualitative identification and differentiation of general coliforms, E. coli, Aeromonas spp and Salmonella spp in a test sample
US7323488B2 (en) * 2001-10-24 2008-01-29 Michael Burton Chromogenic enzyme substrates
PL2896397T5 (pl) 2003-08-01 2023-06-19 Mitsubishi Tanabe Pharma Corporation Nowe związki mające działanie inhibitujące zależny od sodu transporter glukozy
AR048282A1 (es) * 2003-08-01 2006-04-19 Janssen Pharmaceutica Nv Indol- o - glucosidos sustituidos
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
DE102005026500B4 (de) * 2005-06-09 2008-05-15 Philipps-Universität Marburg Herstellung von N-Arylcarbamaten und N-Arylisocyanaten
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
US9024009B2 (en) * 2007-09-10 2015-05-05 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
FR2924127B1 (fr) 2007-11-26 2013-02-08 Biomerieux Sa Milieu reactionnel pour la detection et/ou l'identification de staphyloccocus aureus
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
DK2451797T3 (da) 2009-07-10 2013-06-24 Janssen Pharmaceutica Nv Fremgangsmåde til krystallisation for 1-(b-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-fluorphenyl)-2- thienylmethyl]benzen
SG10201500258WA (en) * 2009-10-14 2015-03-30 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
KR101931209B1 (ko) 2010-05-11 2018-12-20 얀센 파마슈티카 엔.브이. Sglt의 억제제로서 1-(베타-d-글루코피라노실)-2-티에닐-메틸벤젠 유도체를 포함하는 약학 제형
JP5973551B2 (ja) 2011-04-13 2016-08-23 ヤンセン ファーマシューティカ エヌ．ベー． Ｓｇｌｔ２の阻害物質として有用な化合物の調製プロセス
US9035044B2 (en) 2011-05-09 2015-05-19 Janssen Pharmaceutica Nv L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
CN103333817B (zh) * 2013-06-05 2015-07-01 南昌大学 磁分离小肠结肠炎耶尔森氏菌ye的方法
GB201319768D0 (en) 2013-11-08 2013-12-25 Glycosynth Ltd Naphthalene derived chromogenic enzyme substrates
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
CN111393352A (zh) * 2020-04-21 2020-07-10 中国科学院化学研究所 5-溴-6-氯-3-羟基吲哚-2-甲酸甲酯化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364767A (en) * 1993-02-11 1994-11-15 Research Organics, In. Chromogenic compounds and methods of using same
JPH093090A (ja) * 1995-06-21 1997-01-07 Sankyo Co Ltd 新規化合物ａ−７６２０２ｍ及びその製法
US6379911B2 (en) 1996-02-23 2002-04-30 Albert Einstein College Of Medicine Of Yeshiva University Enzyme detection/assay method and substrates
FR2770538B1 (fr) 1997-11-06 2000-10-13 Bio Merieux Procede et agent de detection et d'identification et/ou quantification d'une activite enzymatique de type desaminase
JP2000186098A (ja) * 1998-12-22 2000-07-04 Sankyo Co Ltd Ａ−７６２０２及びその類縁化合物の製造方法
US6350588B1 (en) * 1999-07-20 2002-02-26 Micrology Laboratories, Llc Test media and quantitative or qualitative method for identification and differentiation of biological materials in a test sample
GB0125532D0 (en) * 2001-10-24 2001-12-12 Burton Michael Enzyme activity indicators
US7323488B2 (en) * 2001-10-24 2008-01-29 Michael Burton Chromogenic enzyme substrates

Also Published As

Publication number Publication date
WO2003035897A3 (en) 2004-04-22
DE60208063T2 (de) 2006-08-17
EP1436411B1 (de) 2005-12-14
WO2003035896A3 (en) 2004-04-22
ES2254745T3 (es) 2006-06-16
US7323488B2 (en) 2008-01-29
DE60208063D1 (de) 2006-01-19
ES2256535T3 (es) 2006-07-16
EP1438424A2 (de) 2004-07-21
EP1436411A2 (de) 2004-07-14
US7709223B2 (en) 2010-05-04
DE60208809T2 (de) 2006-11-02
US7384763B2 (en) 2008-06-10
AU2002337302A1 (en) 2003-05-06
EP1438424B1 (de) 2006-01-18
US20080193959A1 (en) 2008-08-14
AU2002336205A1 (en) 2003-05-06
DE60208809D1 (de) 2006-04-06
US20050124556A1 (en) 2005-06-09
WO2003035897A2 (en) 2003-05-01
WO2003035896A2 (en) 2003-05-01
ATE316148T1 (de) 2006-02-15
US20040259181A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
DE60208063D1 (de) Chromogenischen enzymsubstraten und verfahren zum nachweis von beta-d-ribofuranosidase-wirksamkeit
DE60315043D1 (de) Nachweis biologischer moleküle mittels differentieller aufteilung von enzymsubstraten und -produkten
ATE342377T1 (de) Spezifische detektionsmedien für staphylococcus aureus und identifizierungs- und/oder zaehlmethode unter verwendung besagter detektionsmedien
TW200613564A (en) Bacteria detection instrument, bacteria detection method and bacteria detection kit
DE60212175D1 (de) Verfahren zur reduzierung unspezifischer amplifikation bei pcr
DE60310583D1 (de) Verfahren zum nachweis von methicillinresistenten staphylococcus aureus
ATE266101T1 (de) Nitrocumarine für den nachweis aller mikroorganismen
DE69732647D1 (de) Verfahren und kulturmedien zum nachweis von hefen und/oder schimmelpilzen in proben
DE60221126D1 (de) Verbessertes verfahren zum nachweis und zur identifizierung eines eine infektion verursachenden mikroorganismus
FR2916763B1 (fr) Nouveaux substrats de peptidase
RU2010144840A (ru) Обнаружение и подсчет микроорганизмов
WO2001059157A3 (en) Process for the enumeration and identification of microorganisms
JP2011509680A5 (de)
FR2801903B1 (fr) Nouveaux substrats enzymatiques pour la detection de pseudomonas aeruginosa, compositions les contenant et procede de detection de cette espece
FR2916762B1 (fr) Nouveaux substrats enzymatiques de nitroreductase
BRPI0113540B8 (pt) meio e processo para detectar campylobacter em uma amostra
ATE377090T1 (de) Verfahren und medium zum nachweisen/identifizieren von mikroorganismen mit esteraseaktivität
JP4585509B2 (ja) 微生物の検出用及び／又は識別用の培地
ATE412062T1 (de) Verfahren und mittel zur detektion enzymatischer spalt- und verknüpfungsreaktionen
ATE307895T1 (de) Verfahren zur identifizierung von listeria- monozytogenen und kulturmedium
ATE361991T1 (de) Verfahren und agens zur bestimmung von deaminase- aktivität
GB2456116A (en) Detection of corrosion-inducing prokaryotes using the dissimilatory sulfate reductase gene
ES2015340A6 (es) Un procedimiento de ensayo sencillo para determinar la presencia de bacterias desnitrificantes en sistemas de agua cerrados.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties